Selected research
Market Outlook & Growth Opportunities
Global Contract Sales Organization (CSO) Market Outlook and Growth Opportunities 2026
Market perspective
The global Contract Sales Organization (CSO) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Contract Sales Organization (CSO) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Contract Sales Organization (CSO) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Contract Sales Organization (CSO) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Contract Sales Organization (CSO) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Contract Sales Organization (CSO) market include China Medical System (CMS), IQVIA, PHOENIX Group, EVERSANA, Ashfield Engage (Inizio), Amplity Health, Sinco Pharma, Syneos Health and EPS Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Contract Sales Organization (CSO) market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Contract Sales Organization (CSO) and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Contract Sales Organization (CSO) revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Contract Sales Organization (CSO) market.
Contract Sales Organization (CSO) Segment by Company
China Medical System (CMS)
IQVIA
PHOENIX Group
EVERSANA
Ashfield Engage (Inizio)
Amplity Health
Sinco Pharma
Syneos Health
EPS Corporation
Uniphar Group
CMIC Group
SciClone Pharmaceuticals
China Pioneer Pharma
Promoveo Health
CSO Pharmitalia
GTS Solution
QFR Solutions
Contract Sales Organization (CSO) Segment by Type
Personal Promotion
Non-personal Promotion
Others
Contract Sales Organization (CSO) Segment by Application
Pharmaceutical Company
Biotechnology Company
Generic Company
Others
Contract Sales Organization (CSO) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Contract Sales Organization (CSO) status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Contract Sales Organization (CSO) key companies, revenue, market share, and recent developments.
3. To split the Contract Sales Organization (CSO) breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Contract Sales Organization (CSO) market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Contract Sales Organization (CSO) significant trends, drivers, influence factors in global and regions.
6. To analyze Contract Sales Organization (CSO) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contract Sales Organization (CSO) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Contract Sales Organization (CSO) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contract Sales Organization (CSO).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Contract Sales Organization (CSO) industry.
Chapter 3: Detailed analysis of Contract Sales Organization (CSO) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Contract Sales Organization (CSO) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Contract Sales Organization (CSO) in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Personal Promotion
- Non-personal Promotion
- Others
Applications
- Pharmaceutical Company
- Biotechnology Company
- Generic Company
- Others
Companies covered
- China Medical System (CMS)
- IQVIA
- PHOENIX Group
- EVERSANA
- Ashfield Engage (Inizio)
- Amplity Health
- Sinco Pharma
- Syneos Health
- EPS Corporation
- Uniphar Group
- CMIC Group
- SciClone Pharmaceuticals
- China Pioneer Pharma
- Promoveo Health
- CSO Pharmitalia
- GTS Solution
- QFR Solutions
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Contract Sales Organization (CSO) Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Contract Sales Organization (CSO) Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Contract Sales Organization (CSO) Market Dynamics
- 2.1 Contract Sales Organization (CSO) Industry Trends
- 2.2 Contract Sales Organization (CSO) Industry Drivers
- 2.3 Contract Sales Organization (CSO) Industry Opportunities and Challenges
- 2.4 Contract Sales Organization (CSO) Industry Restraints
3 Contract Sales Organization (CSO) Market by Company
- 3.1 Global Contract Sales Organization (CSO) Company Revenue Ranking in 2025
- 3.2 Global Contract Sales Organization (CSO) Revenue by Company (2021-2026)
- 3.3 Global Contract Sales Organization (CSO) Company Ranking (2024-2026)
- 3.4 Global Contract Sales Organization (CSO) Company Manufacturing Base and Headquarters
- 3.5 Global Contract Sales Organization (CSO) Company Product Type and Application
- 3.6 Global Contract Sales Organization (CSO) Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Contract Sales Organization (CSO) Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Contract Sales Organization (CSO) Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Contract Sales Organization (CSO) Market by Type
- 4.1 Contract Sales Organization (CSO) Type Introduction
- 4.1.1 Personal Promotion
- 4.1.2 Non-personal Promotion
- 4.1.3 Others
- 4.2 Global Contract Sales Organization (CSO) Sales Value by Type
- 4.2.1 Global Contract Sales Organization (CSO) Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Contract Sales Organization (CSO) Sales Value by Type (2021-2032)
- 4.2.3 Global Contract Sales Organization (CSO) Sales Value Share by Type (2021-2032)
5 Contract Sales Organization (CSO) Market by Application
- 5.1 Contract Sales Organization (CSO) Application Introduction
- 5.1.1 Pharmaceutical Company
- 5.1.2 Biotechnology Company
- 5.1.3 Generic Company
- 5.1.4 Others
- 5.2 Global Contract Sales Organization (CSO) Sales Value by Application
- 5.2.1 Global Contract Sales Organization (CSO) Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Contract Sales Organization (CSO) Sales Value by Application (2021-2032)
- 5.2.3 Global Contract Sales Organization (CSO) Sales Value Share by Application (2021-2032)
6 Contract Sales Organization (CSO) Regional Value Analysis
- 6.1 Global Contract Sales Organization (CSO) Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Contract Sales Organization (CSO) Sales Value by Region (2021-2032)
- 6.2.1 Global Contract Sales Organization (CSO) Sales Value by Region: 2021-2026
- 6.2.2 Global Contract Sales Organization (CSO) Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Contract Sales Organization (CSO) Sales Value (2021-2032)
- 6.3.2 North America Contract Sales Organization (CSO) Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Contract Sales Organization (CSO) Sales Value (2021-2032)
- 6.4.2 Europe Contract Sales Organization (CSO) Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Contract Sales Organization (CSO) Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Contract Sales Organization (CSO) Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Contract Sales Organization (CSO) Sales Value (2021-2032)
- 6.6.2 South America Contract Sales Organization (CSO) Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Contract Sales Organization (CSO) Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Contract Sales Organization (CSO) Sales Value Share by Country, 2025 VS 2032
7 Contract Sales Organization (CSO) Country-level Value Analysis
- 7.1 Global Contract Sales Organization (CSO) Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Contract Sales Organization (CSO) Sales Value by Country (2021-2032)
- 7.2.1 Global Contract Sales Organization (CSO) Sales Value by Country (2021-2026)
- 7.2.2 Global Contract Sales Organization (CSO) Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
- 7.7.2 France Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
- 7.14.2 China Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
- 7.17.2 India Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 China Medical System (CMS)
- 8.1.1 China Medical System (CMS) Company Information
- 8.1.2 China Medical System (CMS) Business Overview
- 8.1.3 China Medical System (CMS) Contract Sales Organization (CSO) Revenue and Gross Margin (2021-2026)
- 8.1.4 China Medical System (CMS) Contract Sales Organization (CSO) Product Portfolio
- 8.1.5 China Medical System (CMS) Recent Developments
- 8.2 IQVIA
- 8.2.1 IQVIA Company Information
- 8.2.2 IQVIA Business Overview
- 8.2.3 IQVIA Contract Sales Organization (CSO) Revenue and Gross Margin (2021-2026)
- 8.2.4 IQVIA Contract Sales Organization (CSO) Product Portfolio
- 8.2.5 IQVIA Recent Developments
- 8.3 PHOENIX Group
- 8.3.1 PHOENIX Group Company Information
- 8.3.2 PHOENIX Group Business Overview
- 8.3.3 PHOENIX Group Contract Sales Organization (CSO) Revenue and Gross Margin (2021-2026)
- 8.3.4 PHOENIX Group Contract Sales Organization (CSO) Product Portfolio
- 8.3.5 PHOENIX Group Recent Developments
- 8.4 EVERSANA
- 8.4.1 EVERSANA Company Information
- 8.4.2 EVERSANA Business Overview
- 8.4.3 EVERSANA Contract Sales Organization (CSO) Revenue and Gross Margin (2021-2026)
- 8.4.4 EVERSANA Contract Sales Organization (CSO) Product Portfolio
- 8.4.5 EVERSANA Recent Developments
- 8.5 Ashfield Engage (Inizio)
- 8.5.1 Ashfield Engage (Inizio) Company Information
- 8.5.2 Ashfield Engage (Inizio) Business Overview
- 8.5.3 Ashfield Engage (Inizio) Contract Sales Organization (CSO) Revenue and Gross Margin (2021-2026)
- 8.5.4 Ashfield Engage (Inizio) Contract Sales Organization (CSO) Product Portfolio
- 8.5.5 Ashfield Engage (Inizio) Recent Developments
- 8.6 Amplity Health
- 8.6.1 Amplity Health Company Information
- 8.6.2 Amplity Health Business Overview
- 8.6.3 Amplity Health Contract Sales Organization (CSO) Revenue and Gross Margin (2021-2026)
- 8.6.4 Amplity Health Contract Sales Organization (CSO) Product Portfolio
- 8.6.5 Amplity Health Recent Developments
- 8.7 Sinco Pharma
- 8.7.1 Sinco Pharma Company Information
- 8.7.2 Sinco Pharma Business Overview
- 8.7.3 Sinco Pharma Contract Sales Organization (CSO) Revenue and Gross Margin (2021-2026)
- 8.7.4 Sinco Pharma Contract Sales Organization (CSO) Product Portfolio
- 8.7.5 Sinco Pharma Recent Developments
- 8.8 Syneos Health
- 8.8.1 Syneos Health Company Information
- 8.8.2 Syneos Health Business Overview
- 8.8.3 Syneos Health Contract Sales Organization (CSO) Revenue and Gross Margin (2021-2026)
- 8.8.4 Syneos Health Contract Sales Organization (CSO) Product Portfolio
- 8.8.5 Syneos Health Recent Developments
- 8.9 EPS Corporation
- 8.9.1 EPS Corporation Company Information
- 8.9.2 EPS Corporation Business Overview
- 8.9.3 EPS Corporation Contract Sales Organization (CSO) Revenue and Gross Margin (2021-2026)
- 8.9.4 EPS Corporation Contract Sales Organization (CSO) Product Portfolio
- 8.9.5 EPS Corporation Recent Developments
- 8.10 Uniphar Group
- 8.10.1 Uniphar Group Company Information
- 8.10.2 Uniphar Group Business Overview
- 8.10.3 Uniphar Group Contract Sales Organization (CSO) Revenue and Gross Margin (2021-2026)
- 8.10.4 Uniphar Group Contract Sales Organization (CSO) Product Portfolio
- 8.10.5 Uniphar Group Recent Developments
- 8.11 CMIC Group
- 8.11.1 CMIC Group Company Information
- 8.11.2 CMIC Group Business Overview
- 8.11.3 CMIC Group Contract Sales Organization (CSO) Revenue and Gross Margin (2021-2026)
- 8.11.4 CMIC Group Contract Sales Organization (CSO) Product Portfolio
- 8.11.5 CMIC Group Recent Developments
- 8.12 SciClone Pharmaceuticals
- 8.12.1 SciClone Pharmaceuticals Company Information
- 8.12.2 SciClone Pharmaceuticals Business Overview
- 8.12.3 SciClone Pharmaceuticals Contract Sales Organization (CSO) Revenue and Gross Margin (2021-2026)
- 8.12.4 SciClone Pharmaceuticals Contract Sales Organization (CSO) Product Portfolio
- 8.12.5 SciClone Pharmaceuticals Recent Developments
- 8.13 China Pioneer Pharma
- 8.13.1 China Pioneer Pharma Company Information
- 8.13.2 China Pioneer Pharma Business Overview
- 8.13.3 China Pioneer Pharma Contract Sales Organization (CSO) Revenue and Gross Margin (2021-2026)
- 8.13.4 China Pioneer Pharma Contract Sales Organization (CSO) Product Portfolio
- 8.13.5 China Pioneer Pharma Recent Developments
- 8.14 Promoveo Health
- 8.14.1 Promoveo Health Company Information
- 8.14.2 Promoveo Health Business Overview
- 8.14.3 Promoveo Health Contract Sales Organization (CSO) Revenue and Gross Margin (2021-2026)
- 8.14.4 Promoveo Health Contract Sales Organization (CSO) Product Portfolio
- 8.14.5 Promoveo Health Recent Developments
- 8.15 CSO Pharmitalia
- 8.15.1 CSO Pharmitalia Company Information
- 8.15.2 CSO Pharmitalia Business Overview
- 8.15.3 CSO Pharmitalia Contract Sales Organization (CSO) Revenue and Gross Margin (2021-2026)
- 8.15.4 CSO Pharmitalia Contract Sales Organization (CSO) Product Portfolio
- 8.15.5 CSO Pharmitalia Recent Developments
- 8.16 GTS Solution
- 8.16.1 GTS Solution Company Information
- 8.16.2 GTS Solution Business Overview
- 8.16.3 GTS Solution Contract Sales Organization (CSO) Revenue and Gross Margin (2021-2026)
- 8.16.4 GTS Solution Contract Sales Organization (CSO) Product Portfolio
- 8.16.5 GTS Solution Recent Developments
- 8.17 QFR Solutions
- 8.17.1 QFR Solutions Company Information
- 8.17.2 QFR Solutions Business Overview
- 8.17.3 QFR Solutions Contract Sales Organization (CSO) Revenue and Gross Margin (2021-2026)
- 8.17.4 QFR Solutions Contract Sales Organization (CSO) Product Portfolio
- 8.17.5 QFR Solutions Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst